- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 5, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article published in Managed Healthcare Executive covers the results of its annual pharmacy survey and references the biosimilars approval tracker on the Center for Biosimilars® website, which lists how many biosimilars have been approved and their product launches worldwide.
A piece by Advisory Board referenced an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Endoscopic Procedure May Eliminate Need for Insulin in Type 2 Diabetes,” discussed the beginning of work on a double-blind randomized controlled trial that would test the results of a preliminary study that found a 1-hour endoscopic procedure could eliminate the need for insulin in patients with type 2 diabetes.
GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?
December 8th 2025Glucagon-like peptide 1 (GLP-1) receptor agonists offer promise in weight and cardiovascular risk reduction, but their use must complement—not replace—lifestyle interventions within a holistic, patient-centered care model.
Read More
